Please login to Zacks.com or register to post a comment.
| No Recent Quote currently available |
|
My Portfolio Tracker One of the most important steps you can take today is to set up your portfolio tracker on Zacks.com. Once you do, you'll be notified of major events affecting your stocks and/or funds with daily email alerts. Set yours up today. |
Zacks Rank Home - Evaluate your stocks and use the Zacks Rank to eliminate the losers and keep the winners.
Mutual Fund Rank Home - Evaluate your funds with the Mutual Fund Rank for both your personal and retirement funds.
Stock/Mutual Fund Screening - Find better stocks and mutual funds. The ones most likely to beat the market and provide a positive return.
My Portfolio - Track your Portfolio and find out where your stocks/mutual funds stack up with the Zacks Rank.
| Company Name | Symbol | %Change |
|---|---|---|
| ALLIANCE FIB | AFOP | 5.21% |
| CYNOSURE INC | CYNO | 4.42% |
| DAWSON GEOPH | DWSN | 4.33% |
| MARRIOTT VAC | VAC | 3.27% |
| BLOOMIN' | BLMN | 2.93% |
Please login to Zacks.com or register to post a comment.
Resources
Client Support
Zacks Research is Reported On:
Zacks Investment Research
is an A+ Rated BBB
Accredited Business.
Copyright 2013 Zacks Investment Research
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1986 it has nearly tripled the S&P 500 with an average gain of +26% per year. These returns cover a period from 1986-2011 and were examined and attested by Baker Tilly, an independent accounting firm.
Visit performance for information about the performance numbers displayed above.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This page is temporarily not available. Please check later as it should be available shortly. If you have any questions, please email customer support at support@zacks.com or call 800-767-3771 ext. 9339.
We maintain our recommendation on ANADIGICS, Inc (ANAD - Analyst Report).
ANADIGICS recently reported weak results in the second quarter of 2011. ANADIGICS reported net sales of $35.6 million in the second quarter of 2011, down 18.1% sequentially and down 31.1% from a year ago. The results were in line with management’s guidance and the Zacks Consensus Estimate of $36 million.
The sequential decline in the second quarter was primarily due to a decrease in shipments of one of the largest North American customers – Research In Motion ().
Gross margin came in at 20%, in line with management’s expectations as the sequential increase in broadband revenue was offset by a sequential decline in wireless revenue and lower quarterly fab utilization. Net loss came in at $13.0 million or ($0.19) per diluted share compared with a net income of $0.8 million or $0.01 per diluted share in the year-ago quarter.
Excluding one-time items but including stock-based compensation, net loss came in at $0.18, better than the Zacks Estimate of $0.20.
Although net loss per share came in better than the Zacks Estimate, we remain concerned about the loss of market share of its key customer, RIMM. Management suspended providing any financial guidance due to the uncertainty in the markets.
ANADIGICS stated that the shift in wireless customer mix, particularly in Korea and China, has led to very short order lead times. Margins continue to be under pressure, primarily due to underutilization of fabs (50% in the second quarter).
We do not see any meaningful catalyst in the near term and do not expect ANADIGICS to return to profitability before 2013. Hence, we maintain our Neutral recommendation.
Read the full reports :
Analyst Report on ANAD